Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin and factor VIII concentrate combination treatment in non-severe hemophilia A during minor interventions
2016-001875-57Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Dec 2016
- Modality
- Small Molecules, Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of desmopressin and Factor VIII in hemophilia A, sponsored by Erasmus MC. Primary endpoint: Deviation of achieved factor VIII peak level from predicted peak range. Started Dec 2016; status: active.
02
Drugs
desmopressinFactor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2016-001875-57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001875-57.